Canada markets open in 2 hours 8 minutes

West Pharmaceutical Services, Inc. (WST)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
385.73-4.47 (-1.15%)
At close: 04:00PM EDT
388.55 +2.82 (+0.73%)
After hours: 06:00PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 28.24B
Enterprise Value 27.69B
Trailing P/E 48.95
Forward P/E 50.51
PEG Ratio (5 yr expected) 6.83
Price/Sales (ttm)9.85
Price/Book (mrq)9.80
Enterprise Value/Revenue 9.39
Enterprise Value/EBITDA 32.80

Trading Information

Stock Price History

Beta (5Y Monthly) 1.02
52-Week Change 38.59%
S&P500 52-Week Change 322.64%
52 Week High 3415.73
52 Week Low 3310.42
50-Day Moving Average 3378.30
200-Day Moving Average 3371.38

Share Statistics

Avg Vol (3 month) 3540.56k
Avg Vol (10 day) 3415.3k
Shares Outstanding 573.21M
Implied Shares Outstanding 674.05M
Float 872.82M
% Held by Insiders 10.56%
% Held by Institutions 196.12%
Shares Short (Apr 15, 2024) 4975.86k
Short Ratio (Apr 15, 2024) 42.72
Short % of Float (Apr 15, 2024) 41.74%
Short % of Shares Outstanding (Apr 15, 2024) 41.33%
Shares Short (prior month Mar 15, 2024) 41.21M

Dividends & Splits

Forward Annual Dividend Rate 40.8
Forward Annual Dividend Yield 40.21%
Trailing Annual Dividend Rate 30.77
Trailing Annual Dividend Yield 30.20%
5 Year Average Dividend Yield 40.26
Payout Ratio 49.77%
Dividend Date 3May 01, 2024
Ex-Dividend Date 4Apr 23, 2024
Last Split Factor 22:1
Last Split Date 3Sept 27, 2013

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 20.12%
Operating Margin (ttm)23.63%

Management Effectiveness

Return on Assets (ttm)11.93%
Return on Equity (ttm)21.32%

Income Statement

Revenue (ttm)2.95B
Revenue Per Share (ttm)39.70
Quarterly Revenue Growth (yoy)3.30%
Gross Profit (ttm)N/A
EBITDA 847.8M
Net Income Avi to Common (ttm)593.4M
Diluted EPS (ttm)7.87
Quarterly Earnings Growth (yoy)33.00%

Balance Sheet

Total Cash (mrq)853.9M
Total Cash Per Share (mrq)11.65
Total Debt (mrq)309M
Total Debt/Equity (mrq)10.73%
Current Ratio (mrq)2.88
Book Value Per Share (mrq)39.20

Cash Flow Statement

Operating Cash Flow (ttm)776.5M
Levered Free Cash Flow (ttm)199.04M